Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Fingolimod for the treatment of neurological diseases-state of play and future perspectives.
Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases.
The Use of Focus Groups to Characterize Symptoms in Persons With Multiple Sclerosis.
Falls in people with MS who use a walking aid: Prevalence, factors and effect of balance and strengthening interventions.
Association of Epstein-Barr virus infection with multiple sclerosis in India.
DTI Measurements in Multiple Sclerosis: Evaluation of Brain Damage and Clinical Implications.
The influence of non-HLA gene polymorphisms and interactions on disease risk in a Western Australian multiple sclerosis cohort.
Anti-aquaporin-4 antibody-positive dorsal midbrain syndrome.
A Further TWEAK to Multiple Sclerosis Pathophysiology.
A nine-year population-based cohort study on the risk of multiple sclerosis in patients with optic neuritis.
Clinical features of patients with Guillain-Barré syndrome at seven hospitals on the East Coast of Australia.
Wnt Signaling in Remyelination in Multiple Sclerosis: Friend or Foe?
Ultrasonographic diagnosis of demyelinating neuropathy.
Demyelination complicating anti-tnf therapy in inflammatory bowel disease (ibd) and other inflammatory disorders (pred4-ukcrn 11988).
The Contribution of Resting State Networks to the Study of Cortical Reorganization in MS.
Guideline for the diagnosis and management of multiple sclerosis in children.
Body-worn sensors capture variability, but not decline, of gait and balance measures in multiple sclerosis over 18 months.
Conversion of adult human peripheral blood mononuclear cells into induced neural stem cell by using episomal vectors.
The effect of triiodothyronine on maturation and differentiation of oligodendrocyte progenitor cells during remyelination following induced demyelination in male albino rat.
Steering through complexity: management approaches in multiple sclerosis.
Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2.
Adherence to Long-Term Interferon Beta-1b Injection Therapy in Patients with Multiple Sclerosis Using an Electronic Diary.
Oral corticosteroids for multiple sclerosis relapse.
Opening locked doors: Integrating a palliative care approach into the management of patients with severe multiple sclerosis.
Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis: Is Intrathecal Anti-CD20 a Therapeutic Option?

Pages